Flexible ADHD Formulations for Complex Patient Needs

In "Flexible ADHD Formulations for Complex Patient Needs," the panelists widen the lens to how formulation, not just molecule, shapes whether a patient can actually tolerate and stick with treatment.

The panel highlights high-functioning autism spectrum disorder as an underdiscussed comorbidity, noting that many autistic patients, even at milder symptom levels, have heightened sensory sensitivity that makes standard pills or capsules difficult to tolerate. These patients often need lower doses and alternative formulations such as liquids, orally disintegrating tablets, or chewables in different flavors, including a newer non-stimulant liquid that can be titrated below the lowest fixed dose. The panel notes this dosing flexibility depends directly on formulation, since a sealed capsule filled with unidentifiable extended-release beads cannot be split or adjusted the way a liquid or chewable can.

Beyond autism spectrum patients, the panel observes that many adults simply do not want the same dose every day of the week. A patient may want tight, full-strength coverage on workdays but a lighter dose on weekends that still curbs impulsivity while preserving appetite for social activities. Because older beaded delivery systems offer little flexibility for this kind of dose adjustment, the panel notes it is a real driver of weekend nonadherence.

The panel also addresses hyperfocus, describing how family members often misread a patient's ability to play video games or Legos for hours as proof they cannot have ADHD, when it actually reflects the same difficulty disengaging attention that also drives distractibility. One panelist compares this to a kind of perseveration distinct from obsessive-compulsive disorder, explaining that even when patients physically move on from a task, their brain often has not caught up. As one panelist puts it, if daily life were as stimulating as a video game, medication would be unnecessary.

"Inside the Technology Behind Extended-Release ADHD Medications" pulls back the curtain on the engineering inside modern extended-release ADHD medications.